This course type is lecture

Molecular Neurodegeneration

29 November - 04 December 2015Wellcome Genome Campus, Hinxton, UK
Deadlines (at 23:59 UTC):
  • Application Deadline Closed

  • Summary

    This highly-regarded course provides a cutting edge examination of the
    molecular basis of neurodegeneration and the development of treatment
    strategies. Many parallels are evident between different
    neurodegenerative diseases and this course will highlight and discuss, in
    detail, the common themes across neurodegenerative processes. Course
    participants will gain an insight into the current understanding of both
    rare and common neurological disorders, the strengths and weaknesses of
    experimental evidence and how this knowledge can be applied to develop
    therapies.

    Target audience

    The course is aimed at individuals working in neurodegenerative research,
    including clinicians, PhD students, post-docs and clinical geneticists.
    Applications are encouraged from academia, clinical and animal
    science as well as the pharmaceutical and biotechnology
    industries. In particular, the course will benefit researchers who
    seek an overarching view of neurodegenerative disorders together with
    associated state of the art research techniques, and wish to gain a new
    perspective on their own studies.



    Please note: To optimise the impact of the course,
    attendance is limited to 25 places.

  • Programme

    The intensive programme provides the opportunity to interact with leading
    international neuroscientists. Participants will be tutored by expert
    researchers from highly regarded international institutions, and speakers
    selected to cover a wide range of neuroscience research interests.

    The course is primarily lecture-based but highly interactive; providing
    an exceptional learning environment. Tutors are available throughout the
    course, both in formal lectures and informal settings. Participants will
    have the unique opportunity to share their own research with tutors,
    speakers and other attendees during the course, during formal poster
    sessions and informal discussions.

    Course topics
    
•  Pathological events in human neurodegeneration

    •  Development of therapeutic approaches

    •  Genetic variation in inherited and sporadic disease

    •  Role of pathogenic proteins 

    •  Use of in vivo models to study neurological pathogenesis


    •  The application of high content approaches

    •  Genome editing: methods and applications

    Learning outcomes
    
•  In-depth understanding of neurodegeneration

    •  Appreciation of the similarities between neurological disorders

    •  Knowledge of the latest experimental techniques being used in
    neuroscience

    •  Recognise transferable intellectual and technical tools

    •  Ability to develop treatment therapies

    •  New ideas and perspectives for own research strategy

    •  Interaction with international leading neuroscientists

  • Instructors / Speakers

    Course tutors
    Mark
    Cookson
    National Institutes of Health, USA (LRRK2)

    Beverly
    Davidson
     The Children’s Hospital of Philadelphia, USA
    (PolyQ diseases & Lysosomal storage diseases)

    Harry
    Orr
     University of Minnesota, USA (Ataxia)

    Nicholas
    Wood
     University College London, UK (Genetics of
    neurodegenerative disease)



    Confirmed speakers

    Susan Ackerman The Jackson Laboratory, USA (RNA and
    neurodegeneration)

    Karen Duff Columbia University, USA (Alzheimer’s
    disease)

    Constantino Iadecola Weill Cornell Medical College,
    USA (Stroke)

    Rick Livesey University of Cambridge, UK (Stem
    cells/IPSC)                         

    Huw Morris University College London, UK (Clinical
    aspects of neurological diseases)

    David Nelson Baylor College of Medicine, USA
    (Fragile X & FXTAS)

    David Rubinsztein University of Cambridge, UK
    (Autophagy)

    Marka van Blitterswijk Mayo Clinic, Jacksonville,
    USA (ALS & dementia)

  • How to Apply

    Prerequisites
    The course is aimed at individuals working in neurodegenerative research,
    including clinicians, PhD students, post-docs and clinical geneticists.
    Applications are encouraged from academia, clinical and animal
    science as well as the pharmaceutical and biotechnology
    industries. In particular, the course will benefit researchers who
    seek an overarching view of neurodegenerative disorders together with
    associated state of the art research techniques, and wish to gain a new
    perspective on their own studies

    Cost
    The
    course is subsidised by the Wellcome Genome Campus
    Advanced Courses and Scientific Conferences Programme. This is a
    residential
    course and there is a fee of £650 towards board and lodging
    for non-commercial applicants. The fee for commercial applicants is
    £1050.

    Applications
    Applications for this course can now be completed online. If you have any
    problems with the online application process, please contact us.

    Please note: Applications
    must be supported by a
    recommendation from a scientific or clinical sponsor (e.g. supervisor or
    head of department). A request for a supporting
    statement will be sent
    to your nominated sponsor automatically during
    the application process.
    Applicants must ensure that their sponsor
    provides this supporting
    statement by the application deadline. Applications without a supporting
    statement cannot be considered.

    Deadlines
    Deadline for Applications: Closed

  • Bursaries

    Bursaries
    To apply for a bursary, please contact the conference organiser by 18
    September 2015


    The following information is required to apply for a bursary:

    – CV

    – Covering letter
    
- Support letter from supervisor